“Access to novel, effective, high-cost medicines” and the Oslo Medicines Initiative (OMI)

Objectives:

• Report back on the work undertaken during the two years of the OMI.
• Discuss with member states and stakeholders, in concrete terms given the statement (final report and policy brief), their interest in working together on key issues to promote access through a joint stakeholder platform based on the OMI principles of solidarity, transparency and sustainability.